Related Funding Opportunities & Updates to Funding:
NIH FUNDING & UPDATES |
Grant Name: | |
Summary: | NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals. |
Due Dates: | First Available Due Date: March 17, 2020 Expiration Date: October 06, 2020 |
Grant Name: | |
Summary: | The purpose of this Funding Opportunity Announcement (FOA) is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune responses. Applicants may include CC, CC derivatives with reproducible genomes and/or CC-RIX mice to accomplish these goals. Research areas supported by this FOA include immune system development, function or regulation; mechanisms governing immune response to infectious pathogens, vaccines or adjuvants; host susceptibility factors and mechanisms of pathogen-induced immunopathology; and immune mechanisms involved in the development and progression of immune-mediated diseases, such as allergy/asthma, autoimmunity, primary immunodeficiency, inflammation, and cell/organ/tissue transplant rejection or tolerance. |
Due Dates: | 9/9/2020; Expiration Date: 9/20/2020 |
Grant Name: | Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) |
Summary: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. |
Due Dates: | 6/29/2020; Expiration Date: 6/30/2020 |
Grant Name: | |
Summary: | Supplement to existing awards; NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. |
Due Dates: | Due Date: 3/19/2020; Expiration Date: 3/31/2021 |
Grant Name: | |
Summary: | that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award. Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA. |
Due Dates: | Continuous Submission |
Grant Name: | Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
Summary: | This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years. |
Due Dates: | 5/13/2020 |
UPDATES:
- NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19). Key takeaway: “When delays occur because the applicant or recipient organization is officially closed or unable to submit grant applications due to the effects of COVID-19, the NIH will consider accepting applications late, on a case-by-case basis.”
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19. Key takeaways: “Recipients may submit late financial and progress reports, if research is delayed due to COVID-19, and may carryover unobligated balances on active grants without requesting prior approval. . . . Recipients may extend the final budget period of the approved project on active grants one time for up to 12 months without requesting prior approval from NIH. . . . If unanticipated costs are identified due to impacts of COVID-19, and unobligated balances are not available to rebudget, recipients may request administrative supplements from the funding ICs.” See also the FDA announcement.
- NIH Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19.Key takeaways: “If a recipient organization’s policy allows for the charging of salaries and benefits during periods when no work is performed due to the effect of COVID-19, regardless of the funding source, including Federal and non-Federal, then such charges to NIH grant awards will be allowable. . . . Institutions affected by COVID-19 may continue to provide stipend payments to fellows and trainees who may be unable to work as a result of or related to COVID-19. Recipients should notify the assigned grants management official, and provide documentation demonstrating the effect of COVID-19, and how long the institution will be affected. . . . Non-refundable costs associated with grant-related travel that has been cancelled due to COVID-19 may be charged to the NIH award if they would have otherwise been allowable. . . . NIH will allow recipients that are affected by COVID-19 to delay submission of any final financial, performance, and other reports required by the terms and conditions of award for the closeout of expired projects, provided that proper notice about the reporting delay is given by the recipient to the agency.”
NSF FUNDING & UPDATES |
Grant Name: | Prototype Development to Combat Novel Coronavirus Disease COVID-19 |
Summary: | The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19). |
Due Dates: | 4/15/2020; Expiration Date: 4/30/2020 |
Grant Name: | Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) |
Summary: | In light of the emergence and spread of the coronavirus disease 2019 (COVID-19) in the United States and abroad, the National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. |
Due Dates: | Various |
Grant Name: | |
Summary: | Through this DCL, the Office of Advanced Cyberinfrastructure within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. Such activities would be funded by the Computational and Data-Enabled Science and Engineering program or the Cyberinfrastructure for Sustained Scientific Innovation program. Proposals in response to this DCL and the NSF DCL on COVID-19 (NSF 20-052) may also request the use of NSF-funded advanced computing resources such as Frontera, Stampede2, Bridges, Comet, and JetStream. To ensure availability of these computing resources, investigators must contact OAC prior to submission of the proposal. |
Due Dates: | Various |
UPDATES:
- NSF Guidance for Major Facilities and Contracts. Key takeaways: “Managing organizations and prime contractors should communicate with appropriate NSF staff for consultation, to keep them informed of status, and to ask any questions you may have. . . . Additional costs incurred related to COVID‐19 should be documented carefully. . . . For questions about allowable costs or other performance/operational issues related to COVID‐19, please contact the PO and G/AO or the COR and CO. Please copy COVID19_DACS@nsf.gov on your request to ensure a timely response.”
OTHER FEDERAL FUNDING |
Grant Name: | HHS Biomedical Advanced Research and Development Authority (BARDA) Novel Coronavirus EZ-BAA |
Summary: | To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak. Under the EZ-BAA, BARDA is looking for: Molecular diagnostic assay for SARS-CoV-2 virus on existing FDA-cleared platform; Point-of-care diagnostic assay for detection of SARS-CoV-2 virus; Diagnostic assay for detection of COVID-19 disease; Nonclinical model development and screening for SARS-CoV-2 virus; Alternate vaccine delivery/administration and adjuvants; and advanced manufacturing technologies |
Due Dates: | deadline is rolling until 2023 |
Grant Name: | |
Summary: | xTechSearch seeks novel, disruptive concepts and dual-use technologies that address Army capability gaps or technology shortfalls |
Due Dates: | March 31, 2020 |
Grant Name: | |
Summary: | This scheme provides travel and subsistence funding to support delivery of technical expertise in the global response to Covid-19. This service is not delivered to, or on behalf of, the Department of Health and Social Care (DHSC)/the National Institute for Health Research (NIHR) and does not constitute a contractual or service agreement, employer/employee or agent/principal relationship between any institution, body or person and the DHSC/NIHR. For the avoidance of doubt, it is the applicant’s responsibility to ensure appropriate duty of care, insurance, safeguarding and all other liabilities are in place and the applicant has institutional support to make this trip and an appropriate institutional support in the destination country. |
Due Dates: | 5/30/2020 |
Grant Name: | |
Summary: | The purpose of Amendment Seven is to: I) Provide a cut-off date for questions for Research Areas 001, 003, 004, and 005. II) Provide responses to questions received regarding the solicitation. |
Due Dates: | 4/9/2020 |
UPDATES:
National Endowment for the Humanities
- NEH Resource Hub. Key takeaways: “NEH is working to continue to serve the public and to accept, review, and process grant applications and awards according to our normal schedule. . . . We understand that COVID-19 may impact your funded project as activities may be postponed or cancelled. Please contact your project officer and grant management specialist through eGMS Reach so we can help you explore options such as extensions, budget revisions, and scope changes.”
National Endowment for the Arts
- NEA Resource Hub. Key takeaway: “Grant application deadlines have not changed, and we look forward to receiving and reviewing our next round of grant applications in the coming weeks.”
Institute of Museum and Library Services
- IMLS Resource Hub. Key takeaway: “For questions about submitting new applications, please contact an IMLS program staff member listed on the landing page for the grant program. For questions about active awards, please contact your IMLS program officer directly by phone, through email, or through your eGMS Reach account.” No guidance has yet been listed on shifts in deadlines or new COVID-19 external grant competitions for the U.S. Department of Commerce (DOC Response), National Aeronautics and Space Administration (NASA Response), U.S. Department of Education (ED Resource Hub), U.S. Department of Defense (DOD Resource Hub), U.S. Agency for International Development (USAID Resource Hub), U.S. Department of Agriculture (USDA Resource Hub), U.S. Department of Labor (DOL Resource Hub), or U.S. Department of Energy (DOE Resource Hub). Notably, many of these departments and agencies have announced industry partnerships, internal laboratory efforts, and other initiatives (see below for examples); more external funding opportunities pertaining to COVID-19 will likely be announced in the near future.
SAMHSA COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance
SBA to Provide Disaster Assistance Loans for Small Businesses Impacted by Coronavirus (COVID-19)
Secretary Azar Announces Historic Expansion of Telehealth Access to Combat COVID-19
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments
FOUNDATIONS / CORPORATE FUNDING & UPDATES |
FUNDING ANNOUNCEMENTS:
California Endowment Announces a $5 Million COVID-19 Response Plan
JPMorgan Chase Makes $50 Million Philanthropic Investment to Help Address COVID-19
Coalition of Nonprofits Calls on Congress for $60 Billion Infusion
Central Indiana COVID-19 Community Economic Relief Fund Launched
Greater Seattle Area Grantmakers Unite to Provide $9.2 million for COVID-19 Response Fund
Bank of America Pledges $100 Million for COVID-19 Response Efforts
Citi Foundation to Provide $15 Million to Support COVID-19 Related Relief Efforts Globally
Truist Financial Corporation Announces a $25 Million Pledge to Address COVID-19 Pandemic
Southwestern Pennsylvania Philanthropies Respond to COVID-19
El Pomar Foundation Establishes Assistance Fund for COVID-19
Bill & Melinda Gates Foundation, Wellcome, and Mastercard COVID-19 Funding
UPDATES:
American Heart Association Update: Inform AHA if your funded projects are placed on hold indefinitely. This could take the form of restrictions on human subject recruitment or visits with enrolled subjects, as well as inaccessibility to laboratories. AHA will support interim-year carryover requests due to suspension of research projects and allow rebudgeting. No-cost-extensions are available as always. Unrefunded charges (conference registration, airline ticket, etc.) incurred with the intent to attend a scientific conference that was subsequently cancelled can be charged to an AHA grant.”
Sloan Foundation Update: No grantee will be penalized for having to delay or modify grant metrics due to disruptions caused by COVID-19. If you anticipate major disruptions to your Sloan-funded project, please reach out to your program officer to discuss the situation.
Russell Sage Foundation Update: Because of the effects of COVID-19 on all facets of American life, the Russell Sage Foundation is changing its immediate priorities for letters of inquiry for the May 21, 2020, deadline. For this deadline, RSF will only consider LOIs that satisfy at least one of the following criteria: (a) The research is so timely and time-sensitive that the project must start before April 1, 2021; or, (b) the research analyzes social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States.
Lumina Foundation Update: We can talk about adjusting, delaying, or waiving terms and timelines of any grant or contract (including interim and final reports) so that you can put your focus where it needs to be right now. We will do what’s best for you and the work to ensure the continued strength of our partners—and the best outcomes. We will continue to consider new grants and contracts advanced by Lumina’s employees. To ensure Lumina’s partners maintain sufficient cash flow, we can accelerate payments under already-approved grants.
RESEARCH DEVELOPMENTS AND RELATED ARTICLES |
Urgent Need for Text & Data Mining Expertise for COVID-19
The NLM released the COVID-19 Open Research Dataset (CORD-19) of scholarly literature related to COVID-19, SARS-CoV-2, and the Coronavirus group. The dataset is the most comprehensive machine-readable Coronavirus literature collection available for data and text mining to date, with over 29,000 articles - more than 13,000 of them a full text.
To make full use of this dataset, the White House Office of Science and Technology Policy (OSTP) has issued a call for tech and AI experts to develop new text and data mining techniques that can be used to help the science community answer high-priority scientific questions related to COVID-19.